Rimonabant: a guide to its use in obese and overweight patients

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.8, 2007-08, pp. : 5-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study

By Florentin M Liberopoulos EN Filippatos TD Kostara C Tselepis A Mikhailidis DP Elisaf M

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2741-2750

Informa Healthcare

Access to resources Recommend Favorite

Rimonabant relieves obesity burden in overweight patients

Inpharma, Vol. 1, Iss. 1526, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Mellitus

By Maetzel A.

PharmacoEconomics, Vol. 21, Iss. 7, 2003-01 ,pp. : 501-512

Adis International

Access to resources Recommend Favorite

Methylnaltrexone: a guide to its use in opioid-induced constipation in patients with advanced illness

Drugs & Therapy Perspectives, Vol. 26, Iss. 12, 2010-12 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Exercise for the Overweight and Obese

Current Pharmaceutical Design, Vol. 17, Iss. 12, 2011-04 ,pp. : 1193-1197

Bentham Science Publishers

Access to resources Recommend Favorite